Article Text

Download PDFPDF
Perils of hidden depths
  1. Anna E Mason,
  2. Murali Varma
  1. Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK
  1. Correspondence to Dr Murali Varma, Cellular Pathology, University Hospital of Wales, Cardiff CF14 4XW, UK; wptmv{at}cf.ac.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Clinical question

A man in his 60s presented with lower urinary tract symptoms. His serum prostate-specific antigen level was 6 ng/mL. A prostate biopsy was performed (figure 1).

Figure 1

Prostate biopsy at various magnifications (H&E).

What is your diagnosis?

  1. Acinar adenocarcinoma.

  2. Benign.

  3. High-grade prostatic intraepithelial neoplasia.

  4. Intraductal carcinoma of prostate.

  5. Prostatic intraepithelial neoplasia-like ductal carcinoma.

The correct answer is after the Discussion.

Discussion

The prostate biopsy shows medium-sized prostate glands with papillary infoldings, tufting and prominent nucleoli (figure 2A–D). The low-power architecture with papillary infoldings is consistent with benign prostate glands. Tufting and nucleolar prominence would however suggest high-grade prostatic intraepithelial neoplasia (PIN).

Figure 2

Prostate biopsy containing medium-sized glands with papillary infoldings (A–C) and prominent nucleoli (B, D). Higher magnification of the larger gland shows stroma containing a single cell with amphophilic cytoplasm (C, D: arrows). Deeper levels revealed …

View Full Text

Footnotes

  • Handling editor Iskander Chaudhry.

  • Contributors The case was identified by MV. The first draft of the manuscript was writtern by AEM. Both authors contributed to subsequent revisions.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.